Dr. Gregory T. Everson is the Chief Scientific Officer of HepQuant, LLC. He received his MD degree from Cornell Medical College, New York, NY and is currently a Professor of Medicine and Director of Hepatology at the University of Colorado, Denver. Dr. Everson has published over 300 original papers, books, and book chapters in peer-reviewed journals that include Hepatology, Clinics in Liver Disease, Gastroenterology, Journal of Hepatology, New England Journal of Medicine, The American Journal of Gastroenterology, Alimentary Pharmacology and Therapeutics, and Expert Reviews in Gastroenterology and Hepatology.
In conjunction with Hedy Weinberg, he has co-authored 5 editions of the popular “self-help” book,
Living with Hepatitis C: A Survivor’s Guide, for patients and families. He is a frequently invited speaker and has presented his work at clinical and scientific meetings nationally and internationally. He is a principal investigator for the HALT-C trial (Hepatitis C Antiviral Long-Term Treatment Against Cirrhosis) for the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health (NIH), and numerous other clinical trials.
Dr. Everson is a member of the American Association for the Study of Liver Diseases (AASLD), the American Society of Transplantation, the International Liver Transplant Society, and the International Association for the Study of the Liver. He is a member of the Transplant Hepatology Committee of the American Board of Internal Medicine and Transplant Hepatology of the Accreditation Council for Graduate Medical Education.
Gregory Everson, MD
- Chief Scientific Officer of HepQuant, LLC
- Fellow of the American College of Physicians
- Fellow of the American Gastroenterological Association
- Professor of Medicine and Director of Hepatology, University of Colorado Denver, Division of Gastroenterology & Hepatology
Want more information?
Have Questions?
Contact HepQuant Now
